about
CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation.Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
P50
description
investigador
@es
researcher
@en
name
Daniel Perez-Witzke
@en
type
label
Daniel Perez-Witzke
@en
prefLabel
Daniel Perez-Witzke
@en
P31
P496
0000-0001-6812-0998